[Table/Fig-4]:
Time to Disease Progression (TTP)
| Intaxel | Taxol | |
|---|---|---|
| Number Randomized | 25 | 24 |
| No. of subjects with Disease Progression | 11 | 9 |
| No. of subjects without Disease Progression (censored) | 14 (56%) | 15(63%) |
| Median TTP (days) | 157 | 222 |
| 95% Lower Confidence Interval TTP (days) | 122 | 134 |
| Hazard Ratio (95% Confidence Limits) | 1.525 (0.612, 3.797) | |
| Log-Rank p-values | 0.3607 | |